Dynamic PET/CT imaging of 18F-(2S, 4R)4-fluoroglutamine in healthy volunteers and oncological patients.
Xiaoxia XuHua ZhuFei LiuYan ZhangJianhua YangLifang ZhangQing XieLin ZhuNan LiHank F KungZhi YangPublished in: European journal of nuclear medicine and molecular imaging (2020)
18F-FGln images may further supplement the diagnostic ability of 18F-FDG in cancer patients and detect metabolic changes in different tumors. Furthermore, the imaging time for 18F-FGln PET/CT needs to be optimized for different cancer types to improve the contrast resolution of tumors.
Keyphrases
- pet ct
- positron emission tomography
- end stage renal disease
- high resolution
- ejection fraction
- chronic kidney disease
- newly diagnosed
- magnetic resonance
- papillary thyroid
- peritoneal dialysis
- prognostic factors
- computed tomography
- squamous cell carcinoma
- rectal cancer
- single molecule
- machine learning
- convolutional neural network
- mass spectrometry
- robot assisted
- contrast enhanced